Janus Henderson, a $500 billion asset manager, has become an active validator on the Avalanche blockchain and invested in Tranched, an onchain credit platform managing $300 million in assets with a $3 billion pipeline. This move supports Janus Henderson's goal to be a tech-forward asset manager by integrating blockchain technology into its operations. The firm also deploys tokenized funds on Avalanche, including a $690 million CLO fund and a Treasury fund, enhancing Avalanche's real-world asset presence. While this partnership boosts credibility for Avalanche and Tranched, it introduces new technical and regulatory challenges for Janus Henderson as it balances traditional asset management with blockchain operations.
Janus Henderson's partnership with Avalanche provides context for readers interested in blockchain developments. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 19, 2026 23:31 WIB: out of 50 priced major cryptocurrencies, 41 rose and 8 fell today. EGLD (MultiversX) rose 4.25% to Rp64.958 with a typical hold time of 86 days and Pluang order activity showing 81% sell and 19% buy. SUSHI (SushiSwap) increased 4.11% to Rp3.913 with 102 days typical hold time and 14% sell / 86% buy order activity. BAT (Basic Attention Token) gained 3.95% to Rp3.270 with 93 days typical hold time and 7% sell / 93% buy order activity.
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
The HCA Healthcare Foundation awarded $25,000 to Waypoint (formerly Virginia Home for Boys and Girls) to expand its network of adults trained to support youth mental wellness across Virginia. This funding supports Waypoint's Therapeutic Resources tea...
Angle Advisors has appointed Chris Gessner as a Managing Director, bringing over 20 years of experience in corporate finance, including lending, private equity, and M&A advisory. Gessner's background spans various transaction types and industries suc...
The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...
Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...
